« Previous
Next »
Journal of Hepatology
Volume 49, Issue 1
, Pages 17-24
, July 2008
What can be revealed by extending the sensitivity of HBsAg detection to below the present limit?
References
- . Hepatitis B: global importance and need for control. Vaccine. 1990;8:S18–S20
- . Global programme for control of hepatitis B infection. Vaccine. 1995;13:S47–S49
- . Hepatitis B virus infection. N Engl J Med. 1997;337:1733–1745
- Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen. N Engl J Med. 1985;312:270–276
- . Occult hepatitis B. Lancet Infect Dis. 2002;2:479–486
- . Analysis of HBV infection after blood transfusion in Japan through investigation of a comprehensive donor specimen repository. Transfusion. 2001;41:878–884
- Highly sensitive hepatitis B surface antigen detection by measuring stable nitroxide radical formation with ESR spectroscopy. Free Radic Biol Med. 1998;25:929–935
- Clinical significance of a highly sensitive enzyme immunoassay of hepatitis B surface antigen using a novel electron spin resonance technique. J Med Virol. 2002;66:166–170
- . A novel ESR method for horseradish peroxidase activity using a combination of p-acetamdophenol and hydroxylamine, and its application to enzyme immunoassays. Anal Sci. 1998;14:1107–1113
- Development of real-time detection direct test for hepatitis B virus and comparison with two commercial tests using the WHO international standard. J Gastroenterol Hepatol. 2003;18:1264–1271
- Monitoring low level hepatitis B virus by a newly developed sensitive test. Hepatol Res. 2003;26:281–286
- . Stable expression and replication of hepatitis B virus genome in an integrated state in a human hepatoma cell line transfected with the cloned viral DNA. Proc Natl Acad Sci USA. 1987;84:444–448
- “Silent” hepatitis B virus mutants are responsible for non-A, non-B, non-C, non-D, non-E hepatitis. Microbiol Immunol. 1994;38:281–285
- . Occult hepatitis B virus infection. Transfus Clin Biol. 2004;11:18–25
- . Occult hepatitis B virus infection. J Hepatol. 2007;46:160–170
- . Characterization of unusual escape variants of hepatitis B virus isolated from a hepatitis B surface antigen-negative subject. J Virol. 1998;72:7692–7696
- . Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely occult?. Hepatology. 2001;34:194–203
- . Occult hepatitis B virus infection in chronic liver disease: full-length genome and analysis of mutant surface promoter. Gastroenterology. 2004;127:1356–1371
- . Clearance of HBsAg in seven patients with chronic hepatitis B. Hepatology. 1992;16:1334–1337
- The natural history of asymptomatic hepatitis B surface antigen carriers. Ann Int Med. 1993;118:191–194
- . Global control of hepatitis B virus infection. Lancet Infect Dis. 2002;2:395–403
- . Hepatitis B virions isolated with antibodies to the pre-S1 domain reveal occult viremia by PCR in Alaska Native HBV carriers who have seroconverted. Transfusion. 2000;40:910–916
- Transmission of hepatitis B from hepatitis-B-seronegative subjects. Lancet. 1988;2:1273–1276
- . High prevalence of occult hepatitis B in Baltimore injection drug users. Hepatology. 2004;39:51–57
☆ The authors who have taken part in the research of this paper declared that they do not have a relationship with the manufacturers of the materials involved either in the past or present and they did not receive funding from the manufacturers to carry out their research. Dr. Kainuma is an employee of Tohoku Seiki Industries, Ltd., Yamagata, Japan.
PII: S0168-8278(08)00237-7
doi: 10.1016/j.jhep.2008.03.019
© 2008 European Association for the Study of the Liver. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Hepatology
Volume 49, Issue 1
, Pages 17-24
, July 2008
